According to the manufacturer: The decision to breastfeed during therapy with injectable weight loss medication should consider the risk of infant exposure, the benefits of breastfeeding to the infant, and benefits of treatment to the mother
O'Connor JE, Costell M, Grisolia S (1984) Protective effect of L-carnitine on hyperammonemia
10.1196/annals.1366.012 Ann
Women also experience nausea at higher rates
Weight loss outcomes while taking semaglutide GLP-1 can vary significantly from case to case based on individual factors such as your diet routines, exercise habits, metabolism, and overall health
Your healthcare provider may recommend this combination if you have type 2 diabetes, significant weight loss goals, and cardiovascular risk factors